Reaction
Carcinoid Tumour reporting signals
As of the last recalculation, Carcinoid Tumour appears in 744 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is OCTREOTIDE ACETATE (PRR 400.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Octreotide Acetate | 276 | 400.1 | 403.8 |
| Everolimus | 48 | 28.1 | 28.2 |
| Lanreotide Acetate | 6 | 21.6 | 21.6 |
| Everolimus Tablets | 10 | 16.9 | 16.9 |
| Ranitidine Hydrochloride | 30 | 16.0 | 16.1 |
| Sunitinib Malate | 17 | 12.4 | 12.4 |